Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher Were
Observed name:
Were, Christopher
Institutions:
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (United States)
Observed institutions:
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (United States)
OpenAlex ID:
A5108780922
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
2022
·
Marie Stolbrink
, Martha J. Chinouya
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
29
Cost and consequences of using 7.1 % chlorhexidine gel for newborn umbilical cord care in Kenya
2021
·
Lecia Brown
, Alan Martin
, et al.
·
BMC Health Services Research
·
2
PDF
Effectiveness of innovative training models in building capacity of frontline health workers to manage Non-communicable diseases. A cross-sectional study in four counties in Kenya
2019
·
Sarah kosgei
, Colleta Kiilu
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
12
Citation count:
31
H-index:
2
I10-index:
1
Year
Topic
Type